Exabis Library
Welcome to the e-CCO Library!
P337: Early infliximab clearance predicts remission in children with Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P337: Efficacy of intravenous cyclosporine in fulminant steroid-refractory ulcerative colitis with massive bleeding: a retrospective, observational study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P337: Low seroprevalence of celiac disease in a large screening study in unselected Swiss IBD cohort patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P337: Switching from originator infliximab to CT-P13: single-centre experience from the UK
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P337: Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P338 The effectiveness of a standardised biologic care pathway in the management and treatment of inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P338: Early proactive drug monitoring strategy of infliximab as monotherapy for inflammatory bowel disease in paediatric patients is associated with good sustained clinical remission
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P338: effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of Geteccu
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P338: Long-term complications in patients with fistulising Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P338: Outcome of hospitalised patients with inflammatory bowel disease complicated by Clostridium difficile infection: Results from a tertiary referral centre
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P338: Rate and predictors of mucosal healing in patients with ulcerative colitis treated with thiopurines: results of a multicentric cohort study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P338: Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P338: Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P339 Assessment of DNA-thioguanine nucleotide identifies patients at risk of thiopurine-induced leukopoenia in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P339: Application of Bayesian modelling with infliximab to determine optimal patient-specific regimens
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P339: Crohn’s disease and self-monitoring through a mobile App: The Medicrohn study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P339: Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P339: MadCAM1 expression in intestinal lamina propria endothelium varies among inflammatory bowel disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P339: Pregnant women with perianal Crohn’s Disease: suggestions for the improvement of the current guideline on delivery method
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P339: The efficacy of intravenous iron therapy in IBD patients with active disease is not influenced by the degree of inflammatory activity
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM